Glucotrol xl and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucotrol xl and Adalat. Common interactions include nausea among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people who take Glucotrol xl and Adalat have. It is created by eHealthMe based on reports of 24 people who take Glucotrol xl and Adalat from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 24, 2023

24 people who take Glucotrol xl and Adalat together, and have interactions are studied.


What is Glucotrol xl?

Glucotrol xl has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 6,800 Glucotrol xl users for its effectiveness, alternative drugs and more.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,317 Adalat users for its effectiveness, alternative drugs and more.

Number of Glucotrol xl and Adalat reports submitted per year:

Glucotrol xl and Adalat drug interactions.

Common Glucotrol Xl and Adalat drug interactions by gender *:

female:

  1. Nausea
  2. Abdominal distension
  3. Hyperglycaemia
  4. Upper gastrointestinal haemorrhage
  5. Abdominal pain
  6. Abdominal pain upper
  7. Amnesia
  8. Anxiety
  9. Arterial stent insertion
  10. Asthenia

male:

  1. Drug ineffective
  2. Myalgia
  3. Dyspnoea exertional
  4. Fatigue
  5. Headache
  6. Heart rate increased
  7. Hyperglycaemia
  8. Muscle weakness
  9. Nausea
  10. Peritonitis

Common Glucotrol Xl and Adalat drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nausea
  2. Oliguria

40-49:

  1. Hypoglycaemia

50-59:

  1. Appetite decreased
  2. Asthenia
  3. Cardiovascular disorder
  4. Constipation
  5. Dyspnoea exertional
  6. Fatigue
  7. Heart rate increased
  8. Hyperglycaemia
  9. Myalgia
  10. Nausea

60+:

  1. Abdominal distension
  2. Cerebrovascular accident
  3. Cardio-respiratory arrest
  4. Chest pain
  5. Coombs positive haemolytic anaemia
  6. Depression
  7. Emotional distress
  8. Eye disorder
  9. Fatigue
  10. Haematemesis

Common conditions people have *:

  1. Type 2 Diabetes: 2 people, 8.33%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glucotrol xl and Adalat?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Glucotrol xl and Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glucotrol xl side effects:

Browse all side effects of Glucotrol xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Adalat side effects:

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glucotrol xl interactions:

Browse all interactions between Glucotrol xl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Adalat interactions:

Browse all interactions between Adalat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glipizide and nifedipine (the active ingredients of Glucotrol xl and Adalat, respectively), and Glucotrol xl and Adalat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glucotrol xl and Adalat.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: